Genetic Technologies Limited
Hedge Funds Holdings
Last updated:
Genetic Technologies Limited‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 0% of the total amount of its stocks outstanding. This makes up a total of 42.12K shares of Genetic Technologies Limited. Compared to the previous quarter, the number fell by -80.83% or -177.65K shares fewer. As for the holding position changes, 50% (2) of current holders sold a part of the shares held, and 25% (1) closed the holdings completely. 1 hedge funds are new holders of Genetic Technologies Limited stock in Q1 2023, it is 25% of total holders.
Hedge funds holding Genetic Technologies Limited (Q2 2018 – Q1 2023)
Q2 2018 | 11 |
---|---|
Q3 2018 | 11 |
Q4 2018 | 8 |
Q1 2019 | 9 |
Q2 2019 | 11 |
Q3 2019 | 4 |
Q4 2019 | 4 |
Q1 2020 | 4 |
Q2 2020 | 10 |
Q3 2020 | 10 |
Q4 2020 | 12 |
Q1 2021 | 15 |
Q2 2021 | 13 |
Q3 2021 | 9 |
Q4 2021 | 12 |
Q1 2022 | 11 |
Q2 2022 | 11 |
Q3 2022 | 8 |
Q4 2022 | 7 |
Q1 2023 | 4 |
Hedge funds changes in Genetic Technologies Limited positions (Q2 2018 – Q1 2023)
Q2 2018 | 1 | 2 | 3 | 4 | 1 |
---|---|---|---|---|---|
Q3 2018 | 2 | 3 | 2 | 2 | 2 |
Q4 2018 | 0 | 3 | 2 | 3 | 0 |
Q1 2019 | 1 | 3 | 2 | 1 | 2 |
Q2 2019 | 3 | 3 | 1 | 1 | 3 |
Q3 2019 | 4 | 0 | 0 | 11 | -11 |
Q4 2019 | 1 | 1 | 1 | 0 | 1 |
Q1 2020 | 2 | 1 | 1 | 3 | -3 |
Q2 2020 | 6 | 0 | 1 | 0 | 3 |
Q3 2020 | 4 | 2 | 1 | 3 | 0 |
Q4 2020 | 5 | 4 | 1 | 3 | -1 |
Q1 2021 | 5 | 5 | 2 | 2 | 1 |
Q2 2021 | 3 | 4 | 5 | 5 | -4 |
Q3 2021 | 3 | 1 | 4 | 7 | -6 |
Q4 2021 | 5 | 2 | 4 | 2 | -1 |
Q1 2022 | 3 | 2 | 4 | 4 | -2 |
Q2 2022 | 5 | 5 | 0 | 5 | -4 |
Q3 2022 | 2 | 1 | 4 | 5 | -4 |
Q4 2022 | 1 | 3 | 1 | 2 | 0 |
Q1 2023 | 1 | 0 | 2 | 1 | 0 |
Hedge funds changes in Genetic Technologies Limited stock options (Q2 2018 – Q1 2023)
Q2 2018 | 0 | 0 |
---|---|---|
Q3 2018 | 0 | 0 |
Q4 2018 | 0 | 0 |
Q1 2019 | 0 | 0 |
Q2 2019 | 0 | 0 |
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 182,000 | 193,000 |
Q4 2020 | 216,000 | 380,000 |
Q1 2021 | 132,000 | 397,000 |
Q2 2021 | 251,000 | 402,000 |
Q3 2021 | 88,000 | 180,000 |
Q4 2021 | 111,000 | 131,000 |
Q1 2022 | 108,000 | 83,000 |
Q2 2022 | 0 | 0 |
Q3 2022 | 0 | 0 |
Q4 2022 | 0 | 0 |
Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of Genetic Technologies Limited (NASDAQ:GENE)
Hedge fund | Value | Shares owned | Portfolio share |
---|---|---|---|
MORGAN STANLEY | 62K | 52.32K | 0.000% |
CONTINENTAL INVESTORS SERVICES, INC. | 47K | 32K | 0.002% |
OLD MISSION CAPITAL LLC | 39K | 33.49K | 0.001% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 37K | 30.98K | 0.000% |
MILLENNIUM MANAGEMENT LLC Israel Englander | 25K | 20.62K | 0.000% |
CETERA ADVISORS LLC | 16K | 13.96K | 0.000% |
UBS GROUP AG | 4K | 3.37K | 0.000% |
WELLS FARGO & COMPANY/MN | 1K | 1K | 0.000% |
TWO SIGMA SECURITIES, LLC | 0 | 0 | 0.000% |
ROYAL BANK OF CANADA | 0 | 0 | 0.000% |
CITADEL ADVISORS LLC Ken Griffin | 0 | 0 | 0.000% |
GROUND SWELL CAPITAL, LLC | 0 | 0 | 0.000% |